+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Amylase Market By Source: Global Opportunity Analysis and Industry Forecast, 2024-2033

  • PDF Icon

    Report

  • 250 Pages
  • June 2024
  • Region: Global
  • Allied Market Research
  • ID: 5994102
Description Jump to:
The amylase market was valued at $2.7 billion in 2023, and is projected to reach $4.4 billion by 2033, growing at a CAGR of 5.1% from 2024 to 2033.

Amylase is an enzyme that catalyzes the hydrolysis of starch into sugars, and helps in digestion of carbohydrates. This enzyme is majorly synthesized by pancreas and salivary glands. Owing to its ability to break down starches, it finds its application across various industries such as food & beverage, textiles, and paper. In the healthcare sector, amylase levels are measured to assess conditions such as pancreatitis and other digestive disorders.

The growth of the global amylase market is majorly driven by increase in consumer awareness about digestive health and the benefits of enzymes in improving digestion, which has increased the demand for amylase in dietary supplements and functional foods. Moreover, surge in demand for natural and clean label food products has led to the increased use of amylase as a natural additive for improving texture, flavor, and shelf life. In addition, it is used to enhance the quality and consistency of processed foods, such as bread, beer, and cereals, driving its demand in the food industry. Furthermore, increase in environmental concerns and need to adopt on sustainable practices in industries such as agriculture, textiles, paper, and biofuels have boosted the demand for amylase as a biodegradable and non-toxic solution. However, high cost of raw materials utilized in enzyme manufacturing, such as substrates and nutrients, acts as the key deterrent factor of the amylase market. On the contrary, the market is expected to witness lucrative growth opportunities due to ongoing R&D is focused on engineering amylase variants with improved stability, activity, and specificity under various conditions, broadening its application range.

The global amylase market is segmented on the basis of source, type, end use, and region. By source, the market is divided into microbes, plants, and animals. By type, the market is classified into alpha-amylase, beta-amylase, and gamma-amylase. On the basis of end use, it is categorized into food and beverage, textile, paper & pulp, pharmaceutical, and others. Region wise the market is studied across areas such as North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

By source, the microbes segment stands out as the major segment in the amylase market, and is expected to lead throughout by 2033.

On the basis of type, the alpha-amylase segment is expected to exhibit fastest growth throughout the forecast period.

Depending on end use, food & beverages is anticipated to be the prominent segment in the coming years.

Region wise, Asia-Pacific is anticipated to maintain its dominance by 2033.

Competition Analysis

Competitive analysis and profiles of the major players in the global amylase market include Novozymes A/S, DSM, AB Enzymes, Chemzyme Biotechnology Co., Ltd., Sisco Research Laboratories Pvt Ltd, Kerry Group, Biolaxi Corporation, International Flavors & Fragrances Inc., Infinita Biotech Private Limited, Antozyme Biotech Private Limited. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships to strengthen their foothold in the global market during the forecast period.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Additional company profiles with specific to client's interest
  • Additional country or region analysis- market size and forecast
  • Expanded list for Company Profiles
  • SWOT Analysis

Key Market Segments

By Source

  • Microbes
  • Plants
  • Animals

By Type

  • Alpha-amylase
  • Beta-amylase
  • Gamma-amylase

By End-use

  • Food and beverage
  • Textile
  • Paper and pulp
  • Pharmaceutical
  • Others

By Region

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • France
  • Germany
  • Italy
  • Spain
  • UK
  • Rest of Europe
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia-Pacific
  • LAMEA
  • Brazil
  • South Africa
  • Saudi Arabia
  • Rest of LAMEA

Key Market Players

  • Novozymes A/S
  • DSM
  • AB Enzymes
  • Chemzyme Biotechnology Co., Ltd
  • Sisco Research Laboratories Pvt Ltd
  • Kerry Group
  • Biolaxi Corporation
  • International Flavors & Fragrances Inc.
  • Infinita Biotech Private Limited
  • Antozyme Biotech Private Limited

 

Please note:

  • Online Access price format is valid for 60 days access. Printing is not enabled.
  • PDF Single and Enterprise price formats enable printing.

 

Table of Contents

CHAPTER 1: INTRODUCTION
1.1. Report Description
1.2. Key Market Segments
1.3. Key Benefits
1.4. Research Methodology
1.4.1. Primary Research
1.4.2. Secondary Research
1.4.3. Analyst Tools and Models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET LANDSCAPE
3.1. Market Definition and Scope
3.2. Key Findings
3.2.1. Top Investment Pockets
3.2.2. Top Winning Strategies
3.3. Porter's Five Forces Analysis
3.3.1. Bargaining Power of Suppliers
3.3.2. Threat of New Entrants
3.3.3. Threat of Substitutes
3.3.4. Competitive Rivalry
3.3.5. Bargaining Power among Buyers
3.4. Market Dynamics
3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities
CHAPTER 4: AMYLASE MARKET, BY SOURCE
4.1. Market Overview
4.1.1 Market Size and Forecast, By Source
4.2. Microbes
4.2.1. Key Market Trends, Growth Factors and Opportunities
4.2.2. Market Size and Forecast, By Region
4.2.3. Market Share Analysis, By Country
4.3. Plants
4.3.1. Key Market Trends, Growth Factors and Opportunities
4.3.2. Market Size and Forecast, By Region
4.3.3. Market Share Analysis, By Country
4.4. Animals
4.4.1. Key Market Trends, Growth Factors and Opportunities
4.4.2. Market Size and Forecast, By Region
4.4.3. Market Share Analysis, By Country
CHAPTER 5: AMYLASE MARKET, BY TYPE
5.1. Market Overview
5.1.1 Market Size and Forecast, By Type
5.2. Alpha-amylase
5.2.1. Key Market Trends, Growth Factors and Opportunities
5.2.2. Market Size and Forecast, By Region
5.2.3. Market Share Analysis, By Country
5.3. Beta-amylase
5.3.1. Key Market Trends, Growth Factors and Opportunities
5.3.2. Market Size and Forecast, By Region
5.3.3. Market Share Analysis, By Country
5.4. Gamma-amylase
5.4.1. Key Market Trends, Growth Factors and Opportunities
5.4.2. Market Size and Forecast, By Region
5.4.3. Market Share Analysis, By Country
CHAPTER 6: AMYLASE MARKET, BY END-USE
6.1. Market Overview
6.1.1 Market Size and Forecast, By End-use
6.2. Food And Beverage
6.2.1. Key Market Trends, Growth Factors and Opportunities
6.2.2. Market Size and Forecast, By Region
6.2.3. Market Share Analysis, By Country
6.3. Textile
6.3.1. Key Market Trends, Growth Factors and Opportunities
6.3.2. Market Size and Forecast, By Region
6.3.3. Market Share Analysis, By Country
6.4. Paper And Pulp
6.4.1. Key Market Trends, Growth Factors and Opportunities
6.4.2. Market Size and Forecast, By Region
6.4.3. Market Share Analysis, By Country
6.5. Pharmaceutical
6.5.1. Key Market Trends, Growth Factors and Opportunities
6.5.2. Market Size and Forecast, By Region
6.5.3. Market Share Analysis, By Country
6.6. Others
6.6.1. Key Market Trends, Growth Factors and Opportunities
6.6.2. Market Size and Forecast, By Region
6.6.3. Market Share Analysis, By Country
CHAPTER 7: AMYLASE MARKET, BY REGION
7.1. Market Overview
7.1.1 Market Size and Forecast, By Region
7.2. North America
7.2.1. Key Market Trends and Opportunities
7.2.2. Market Size and Forecast, By Source
7.2.3. Market Size and Forecast, By Type
7.2.4. Market Size and Forecast, By End-use
7.2.5. Market Size and Forecast, By Country
7.2.6. U.S. Amylase Market
7.2.6.1. Market Size and Forecast, By Source
7.2.6.2. Market Size and Forecast, By Type
7.2.6.3. Market Size and Forecast, By End-use
7.2.7. Canada Amylase Market
7.2.7.1. Market Size and Forecast, By Source
7.2.7.2. Market Size and Forecast, By Type
7.2.7.3. Market Size and Forecast, By End-use
7.2.8. Mexico Amylase Market
7.2.8.1. Market Size and Forecast, By Source
7.2.8.2. Market Size and Forecast, By Type
7.2.8.3. Market Size and Forecast, By End-use
7.3. Europe
7.3.1. Key Market Trends and Opportunities
7.3.2. Market Size and Forecast, By Source
7.3.3. Market Size and Forecast, By Type
7.3.4. Market Size and Forecast, By End-use
7.3.5. Market Size and Forecast, By Country
7.3.6. France Amylase Market
7.3.6.1. Market Size and Forecast, By Source
7.3.6.2. Market Size and Forecast, By Type
7.3.6.3. Market Size and Forecast, By End-use
7.3.7. Germany Amylase Market
7.3.7.1. Market Size and Forecast, By Source
7.3.7.2. Market Size and Forecast, By Type
7.3.7.3. Market Size and Forecast, By End-use
7.3.8. Italy Amylase Market
7.3.8.1. Market Size and Forecast, By Source
7.3.8.2. Market Size and Forecast, By Type
7.3.8.3. Market Size and Forecast, By End-use
7.3.9. Spain Amylase Market
7.3.9.1. Market Size and Forecast, By Source
7.3.9.2. Market Size and Forecast, By Type
7.3.9.3. Market Size and Forecast, By End-use
7.3.10. UK Amylase Market
7.3.10.1. Market Size and Forecast, By Source
7.3.10.2. Market Size and Forecast, By Type
7.3.10.3. Market Size and Forecast, By End-use
7.3.11. Rest Of Europe Amylase Market
7.3.11.1. Market Size and Forecast, By Source
7.3.11.2. Market Size and Forecast, By Type
7.3.11.3. Market Size and Forecast, By End-use
7.4. Asia-Pacific
7.4.1. Key Market Trends and Opportunities
7.4.2. Market Size and Forecast, By Source
7.4.3. Market Size and Forecast, By Type
7.4.4. Market Size and Forecast, By End-use
7.4.5. Market Size and Forecast, By Country
7.4.6. China Amylase Market
7.4.6.1. Market Size and Forecast, By Source
7.4.6.2. Market Size and Forecast, By Type
7.4.6.3. Market Size and Forecast, By End-use
7.4.7. Japan Amylase Market
7.4.7.1. Market Size and Forecast, By Source
7.4.7.2. Market Size and Forecast, By Type
7.4.7.3. Market Size and Forecast, By End-use
7.4.8. India Amylase Market
7.4.8.1. Market Size and Forecast, By Source
7.4.8.2. Market Size and Forecast, By Type
7.4.8.3. Market Size and Forecast, By End-use
7.4.9. South Korea Amylase Market
7.4.9.1. Market Size and Forecast, By Source
7.4.9.2. Market Size and Forecast, By Type
7.4.9.3. Market Size and Forecast, By End-use
7.4.10. Australia Amylase Market
7.4.10.1. Market Size and Forecast, By Source
7.4.10.2. Market Size and Forecast, By Type
7.4.10.3. Market Size and Forecast, By End-use
7.4.11. Rest of Asia-Pacific Amylase Market
7.4.11.1. Market Size and Forecast, By Source
7.4.11.2. Market Size and Forecast, By Type
7.4.11.3. Market Size and Forecast, By End-use
7.5. LAMEA
7.5.1. Key Market Trends and Opportunities
7.5.2. Market Size and Forecast, By Source
7.5.3. Market Size and Forecast, By Type
7.5.4. Market Size and Forecast, By End-use
7.5.5. Market Size and Forecast, By Country
7.5.6. Brazil Amylase Market
7.5.6.1. Market Size and Forecast, By Source
7.5.6.2. Market Size and Forecast, By Type
7.5.6.3. Market Size and Forecast, By End-use
7.5.7. South Africa Amylase Market
7.5.7.1. Market Size and Forecast, By Source
7.5.7.2. Market Size and Forecast, By Type
7.5.7.3. Market Size and Forecast, By End-use
7.5.8. Saudi Arabia Amylase Market
7.5.8.1. Market Size and Forecast, By Source
7.5.8.2. Market Size and Forecast, By Type
7.5.8.3. Market Size and Forecast, By End-use
7.5.9. Rest of LAMEA Amylase Market
7.5.9.1. Market Size and Forecast, By Source
7.5.9.2. Market Size and Forecast, By Type
7.5.9.3. Market Size and Forecast, By End-use
CHAPTER 8: COMPETITIVE LANDSCAPE
8.1. Introduction
8.2. Top Winning Strategies
8.3. Product Mapping Of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Top Player Positioning, 2023
CHAPTER 9: COMPANY PROFILES
9.1. Novozymes A/S
9.1.1. Company Overview
9.1.2. Key Executives
9.1.3. Company Snapshot
9.1.4. Operating Business Segments
9.1.5. Product Portfolio
9.1.6. Business Performance
9.1.7. Key Strategic Moves and Developments
9.2. DSM
9.2.1. Company Overview
9.2.2. Key Executives
9.2.3. Company Snapshot
9.2.4. Operating Business Segments
9.2.5. Product Portfolio
9.2.6. Business Performance
9.2.7. Key Strategic Moves and Developments
9.3. AB Enzymes
9.3.1. Company Overview
9.3.2. Key Executives
9.3.3. Company Snapshot
9.3.4. Operating Business Segments
9.3.5. Product Portfolio
9.3.6. Business Performance
9.3.7. Key Strategic Moves and Developments
9.4. Chemzyme Biotechnology Co., Ltd
9.4.1. Company Overview
9.4.2. Key Executives
9.4.3. Company Snapshot
9.4.4. Operating Business Segments
9.4.5. Product Portfolio
9.4.6. Business Performance
9.4.7. Key Strategic Moves and Developments
9.5. Sisco Research Laboratories Pvt Ltd
9.5.1. Company Overview
9.5.2. Key Executives
9.5.3. Company Snapshot
9.5.4. Operating Business Segments
9.5.5. Product Portfolio
9.5.6. Business Performance
9.5.7. Key Strategic Moves and Developments
9.6. Kerry Group
9.6.1. Company Overview
9.6.2. Key Executives
9.6.3. Company Snapshot
9.6.4. Operating Business Segments
9.6.5. Product Portfolio
9.6.6. Business Performance
9.6.7. Key Strategic Moves and Developments
9.7. Biolaxi Corporation
9.7.1. Company Overview
9.7.2. Key Executives
9.7.3. Company Snapshot
9.7.4. Operating Business Segments
9.7.5. Product Portfolio
9.7.6. Business Performance
9.7.7. Key Strategic Moves and Developments
9.8. International Flavors And Fragrances Inc.
9.8.1. Company Overview
9.8.2. Key Executives
9.8.3. Company Snapshot
9.8.4. Operating Business Segments
9.8.5. Product Portfolio
9.8.6. Business Performance
9.8.7. Key Strategic Moves and Developments
9.9. Infinita Biotech Private Limited
9.9.1. Company Overview
9.9.2. Key Executives
9.9.3. Company Snapshot
9.9.4. Operating Business Segments
9.9.5. Product Portfolio
9.9.6. Business Performance
9.9.7. Key Strategic Moves and Developments
9.10. Antozyme Biotech Private Limited
9.10.1. Company Overview
9.10.2. Key Executives
9.10.3. Company Snapshot
9.10.4. Operating Business Segments
9.10.5. Product Portfolio
9.10.6. Business Performance
9.10.7. Key Strategic Moves and Developments
LIST OF TABLES
TABLE 1. GLOBAL AMYLASE MARKET, BY SOURCE, 2024 - 2033 ($BILLION)
TABLE 2. GLOBAL AMYLASE MARKET, BY SOURCE, 2024 - 2033 (KILOTON)
TABLE 3. AMYLASE MARKET FOR MICROBES, BY REGION, 2024 - 2033 ($BILLION)
TABLE 4. AMYLASE MARKET FOR MICROBES, BY REGION, 2024 - 2033 (KILOTON)
TABLE 5. AMYLASE MARKET FOR PLANTS, BY REGION, 2024 - 2033 ($BILLION)
TABLE 6. AMYLASE MARKET FOR PLANTS, BY REGION, 2024 - 2033 (KILOTON)
TABLE 7. AMYLASE MARKET FOR ANIMALS, BY REGION, 2024 - 2033 ($BILLION)
TABLE 8. AMYLASE MARKET FOR ANIMALS, BY REGION, 2024 - 2033 (KILOTON)
TABLE 9. GLOBAL AMYLASE MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 10. GLOBAL AMYLASE MARKET, BY TYPE, 2024 - 2033 (KILOTON)
TABLE 11. AMYLASE MARKET FOR ALPHA-AMYLASE, BY REGION, 2024 - 2033 ($BILLION)
TABLE 12. AMYLASE MARKET FOR ALPHA-AMYLASE, BY REGION, 2024 - 2033 (KILOTON)
TABLE 13. AMYLASE MARKET FOR BETA-AMYLASE, BY REGION, 2024 - 2033 ($BILLION)
TABLE 14. AMYLASE MARKET FOR BETA-AMYLASE, BY REGION, 2024 - 2033 (KILOTON)
TABLE 15. AMYLASE MARKET FOR GAMMA-AMYLASE, BY REGION, 2024 - 2033 ($BILLION)
TABLE 16. AMYLASE MARKET FOR GAMMA-AMYLASE, BY REGION, 2024 - 2033 (KILOTON)
TABLE 17. GLOBAL AMYLASE MARKET, BY END-USE, 2024 - 2033 ($BILLION)
TABLE 18. GLOBAL AMYLASE MARKET, BY END-USE, 2024 - 2033 (KILOTON)
TABLE 19. AMYLASE MARKET FOR FOOD AND BEVERAGE, BY REGION, 2024 - 2033 ($BILLION)
TABLE 20. AMYLASE MARKET FOR FOOD AND BEVERAGE, BY REGION, 2024 - 2033 (KILOTON)
TABLE 21. AMYLASE MARKET FOR TEXTILE, BY REGION, 2024 - 2033 ($BILLION)
TABLE 22. AMYLASE MARKET FOR TEXTILE, BY REGION, 2024 - 2033 (KILOTON)
TABLE 23. AMYLASE MARKET FOR PAPER AND PULP, BY REGION, 2024 - 2033 ($BILLION)
TABLE 24. AMYLASE MARKET FOR PAPER AND PULP, BY REGION, 2024 - 2033 (KILOTON)
TABLE 25. AMYLASE MARKET FOR PHARMACEUTICAL, BY REGION, 2024 - 2033 ($BILLION)
TABLE 26. AMYLASE MARKET FOR PHARMACEUTICAL, BY REGION, 2024 - 2033 (KILOTON)
TABLE 27. AMYLASE MARKET FOR OTHERS, BY REGION, 2024 - 2033 ($BILLION)
TABLE 28. AMYLASE MARKET FOR OTHERS, BY REGION, 2024 - 2033 (KILOTON)
TABLE 29. AMYLASE MARKET, BY REGION, 2024 - 2033 ($BILLION)
TABLE 30. AMYLASE MARKET, BY REGION, 2024 - 2033 (KILOTON)
TABLE 31. NORTH AMERICA AMYLASE MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
TABLE 32. NORTH AMERICA AMYLASE MARKET, BY COUNTRY, 2024 - 2033 (KILOTON)
TABLE 33. NORTH AMERICA AMYLASE MARKET, BY SOURCE, 2024 - 2033 ($BILLION)
TABLE 34. NORTH AMERICA AMYLASE MARKET, BY SOURCE, 2024 - 2033 (KILOTON)
TABLE 35. NORTH AMERICA AMYLASE MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 36. NORTH AMERICA AMYLASE MARKET, BY TYPE, 2024 - 2033 (KILOTON)
TABLE 37. NORTH AMERICA AMYLASE MARKET, BY END-USE, 2024 - 2033 ($BILLION)
TABLE 38. NORTH AMERICA AMYLASE MARKET, BY END-USE, 2024 - 2033 (KILOTON)
TABLE 39. U.S. AMYLASE MARKET, BY SOURCE, 2024 - 2033 ($BILLION)
TABLE 40. U.S. AMYLASE MARKET, BY SOURCE, 2024 - 2033 (KILOTON)
TABLE 41. U.S. AMYLASE MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 42. U.S. AMYLASE MARKET, BY TYPE, 2024 - 2033 (KILOTON)
TABLE 43. U.S. AMYLASE MARKET, BY END-USE, 2024 - 2033 ($BILLION)
TABLE 44. U.S. AMYLASE MARKET, BY END-USE, 2024 - 2033 (KILOTON)
TABLE 45. CANADA AMYLASE MARKET, BY SOURCE, 2024 - 2033 ($BILLION)
TABLE 46. CANADA AMYLASE MARKET, BY SOURCE, 2024 - 2033 (KILOTON)
TABLE 47. CANADA AMYLASE MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 48. CANADA AMYLASE MARKET, BY TYPE, 2024 - 2033 (KILOTON)
TABLE 49. CANADA AMYLASE MARKET, BY END-USE, 2024 - 2033 ($BILLION)
TABLE 50. CANADA AMYLASE MARKET, BY END-USE, 2024 - 2033 (KILOTON)
TABLE 51. MEXICO AMYLASE MARKET, BY SOURCE, 2024 - 2033 ($BILLION)
TABLE 52. MEXICO AMYLASE MARKET, BY SOURCE, 2024 - 2033 (KILOTON)
TABLE 53. MEXICO AMYLASE MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 54. MEXICO AMYLASE MARKET, BY TYPE, 2024 - 2033 (KILOTON)
TABLE 55. MEXICO AMYLASE MARKET, BY END-USE, 2024 - 2033 ($BILLION)
TABLE 56. MEXICO AMYLASE MARKET, BY END-USE, 2024 - 2033 (KILOTON)
TABLE 57. EUROPE AMYLASE MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
TABLE 58. EUROPE AMYLASE MARKET, BY COUNTRY, 2024 - 2033 (KILOTON)
TABLE 59. EUROPE AMYLASE MARKET, BY SOURCE, 2024 - 2033 ($BILLION)
TABLE 60. EUROPE AMYLASE MARKET, BY SOURCE, 2024 - 2033 (KILOTON)
TABLE 61. EUROPE AMYLASE MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 62. EUROPE AMYLASE MARKET, BY TYPE, 2024 - 2033 (KILOTON)
TABLE 63. EUROPE AMYLASE MARKET, BY END-USE, 2024 - 2033 ($BILLION)
TABLE 64. EUROPE AMYLASE MARKET, BY END-USE, 2024 - 2033 (KILOTON)
TABLE 65. FRANCE AMYLASE MARKET, BY SOURCE, 2024 - 2033 ($BILLION)
TABLE 66. FRANCE AMYLASE MARKET, BY SOURCE, 2024 - 2033 (KILOTON)
TABLE 67. FRANCE AMYLASE MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 68. FRANCE AMYLASE MARKET, BY TYPE, 2024 - 2033 (KILOTON)
TABLE 69. FRANCE AMYLASE MARKET, BY END-USE, 2024 - 2033 ($BILLION)
TABLE 70. FRANCE AMYLASE MARKET, BY END-USE, 2024 - 2033 (KILOTON)
TABLE 71. GERMANY AMYLASE MARKET, BY SOURCE, 2024 - 2033 ($BILLION)
TABLE 72. GERMANY AMYLASE MARKET, BY SOURCE, 2024 - 2033 (KILOTON)
TABLE 73. GERMANY AMYLASE MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 74. GERMANY AMYLASE MARKET, BY TYPE, 2024 - 2033 (KILOTON)
TABLE 75. GERMANY AMYLASE MARKET, BY END-USE, 2024 - 2033 ($BILLION)
TABLE 76. GERMANY AMYLASE MARKET, BY END-USE, 2024 - 2033 (KILOTON)
TABLE 77. ITALY AMYLASE MARKET, BY SOURCE, 2024 - 2033 ($BILLION)
TABLE 78. ITALY AMYLASE MARKET, BY SOURCE, 2024 - 2033 (KILOTON)
TABLE 79. ITALY AMYLASE MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 80. ITALY AMYLASE MARKET, BY TYPE, 2024 - 2033 (KILOTON)
TABLE 81. ITALY AMYLASE MARKET, BY END-USE, 2024 - 2033 ($BILLION)
TABLE 82. ITALY AMYLASE MARKET, BY END-USE, 2024 - 2033 (KILOTON)
TABLE 83. SPAIN AMYLASE MARKET, BY SOURCE, 2024 - 2033 ($BILLION)
TABLE 84. SPAIN AMYLASE MARKET, BY SOURCE, 2024 - 2033 (KILOTON)
TABLE 85. SPAIN AMYLASE MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 86. SPAIN AMYLASE MARKET, BY TYPE, 2024 - 2033 (KILOTON)
TABLE 87. SPAIN AMYLASE MARKET, BY END-USE, 2024 - 2033 ($BILLION)
TABLE 88. SPAIN AMYLASE MARKET, BY END-USE, 2024 - 2033 (KILOTON)
TABLE 89. UK AMYLASE MARKET, BY SOURCE, 2024 - 2033 ($BILLION)
TABLE 90. UK AMYLASE MARKET, BY SOURCE, 2024 - 2033 (KILOTON)
TABLE 91. UK AMYLASE MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 92. UK AMYLASE MARKET, BY TYPE, 2024 - 2033 (KILOTON)
TABLE 93. UK AMYLASE MARKET, BY END-USE, 2024 - 2033 ($BILLION)
TABLE 94. UK AMYLASE MARKET, BY END-USE, 2024 - 2033 (KILOTON)
TABLE 95. REST OF EUROPE AMYLASE MARKET, BY SOURCE, 2024 - 2033 ($BILLION)
TABLE 96. REST OF EUROPE AMYLASE MARKET, BY SOURCE, 2024 - 2033 (KILOTON)
TABLE 97. REST OF EUROPE AMYLASE MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 98. REST OF EUROPE AMYLASE MARKET, BY TYPE, 2024 - 2033 (KILOTON)
TABLE 99. REST OF EUROPE AMYLASE MARKET, BY END-USE, 2024 - 2033 ($BILLION)
TABLE 100. REST OF EUROPE AMYLASE MARKET, BY END-USE, 2024 - 2033 (KILOTON)
TABLE 101. ASIA-PACIFIC AMYLASE MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
TABLE 102. ASIA-PACIFIC AMYLASE MARKET, BY COUNTRY, 2024 - 2033 (KILOTON)
TABLE 103. ASIA-PACIFIC AMYLASE MARKET, BY SOURCE, 2024 - 2033 ($BILLION)
TABLE 104. ASIA-PACIFIC AMYLASE MARKET, BY SOURCE, 2024 - 2033 (KILOTON)
TABLE 105. ASIA-PACIFIC AMYLASE MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 106. ASIA-PACIFIC AMYLASE MARKET, BY TYPE, 2024 - 2033 (KILOTON)
TABLE 107. ASIA-PACIFIC AMYLASE MARKET, BY END-USE, 2024 - 2033 ($BILLION)
TABLE 108. ASIA-PACIFIC AMYLASE MARKET, BY END-USE, 2024 - 2033 (KILOTON)
TABLE 109. CHINA AMYLASE MARKET, BY SOURCE, 2024 - 2033 ($BILLION)
TABLE 110. CHINA AMYLASE MARKET, BY SOURCE, 2024 - 2033 (KILOTON)
TABLE 111. CHINA AMYLASE MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 112. CHINA AMYLASE MARKET, BY TYPE, 2024 - 2033 (KILOTON)
TABLE 113. CHINA AMYLASE MARKET, BY END-USE, 2024 - 2033 ($BILLION)
TABLE 114. CHINA AMYLASE MARKET, BY END-USE, 2024 - 2033 (KILOTON)
TABLE 115. JAPAN AMYLASE MARKET, BY SOURCE, 2024 - 2033 ($BILLION)
TABLE 116. JAPAN AMYLASE MARKET, BY SOURCE, 2024 - 2033 (KILOTON)
TABLE 117. JAPAN AMYLASE MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 118. JAPAN AMYLASE MARKET, BY TYPE, 2024 - 2033 (KILOTON)
TABLE 119. JAPAN AMYLASE MARKET, BY END-USE, 2024 - 2033 ($BILLION)
TABLE 120. JAPAN AMYLASE MARKET, BY END-USE, 2024 - 2033 (KILOTON)
TABLE 121. INDIA AMYLASE MARKET, BY SOURCE, 2024 - 2033 ($BILLION)
TABLE 122. INDIA AMYLASE MARKET, BY SOURCE, 2024 - 2033 (KILOTON)
TABLE 123. INDIA AMYLASE MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 124. INDIA AMYLASE MARKET, BY TYPE, 2024 - 2033 (KILOTON)
TABLE 125. INDIA AMYLASE MARKET, BY END-USE, 2024 - 2033 ($BILLION)
TABLE 126. INDIA AMYLASE MARKET, BY END-USE, 2024 - 2033 (KILOTON)
TABLE 127. SOUTH KOREA AMYLASE MARKET, BY SOURCE, 2024 - 2033 ($BILLION)
TABLE 128. SOUTH KOREA AMYLASE MARKET, BY SOURCE, 2024 - 2033 (KILOTON)
TABLE 129. SOUTH KOREA AMYLASE MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 130. SOUTH KOREA AMYLASE MARKET, BY TYPE, 2024 - 2033 (KILOTON)
TABLE 131. SOUTH KOREA AMYLASE MARKET, BY END-USE, 2024 - 2033 ($BILLION)
TABLE 132. SOUTH KOREA AMYLASE MARKET, BY END-USE, 2024 - 2033 (KILOTON)
TABLE 133. AUSTRALIA AMYLASE MARKET, BY SOURCE, 2024 - 2033 ($BILLION)
TABLE 134. AUSTRALIA AMYLASE MARKET, BY SOURCE, 2024 - 2033 (KILOTON)
TABLE 135. AUSTRALIA AMYLASE MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 136. AUSTRALIA AMYLASE MARKET, BY TYPE, 2024 - 2033 (KILOTON)
TABLE 137. AUSTRALIA AMYLASE MARKET, BY END-USE, 2024 - 2033 ($BILLION)
TABLE 138. AUSTRALIA AMYLASE MARKET, BY END-USE, 2024 - 2033 (KILOTON)
TABLE 139. REST OF ASIA-PACIFIC AMYLASE MARKET, BY SOURCE, 2024 - 2033 ($BILLION)
TABLE 140. REST OF ASIA-PACIFIC AMYLASE MARKET, BY SOURCE, 2024 - 2033 (KILOTON)
TABLE 141. REST OF ASIA-PACIFIC AMYLASE MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 142. REST OF ASIA-PACIFIC AMYLASE MARKET, BY TYPE, 2024 - 2033 (KILOTON)
TABLE 143. REST OF ASIA-PACIFIC AMYLASE MARKET, BY END-USE, 2024 - 2033 ($BILLION)
TABLE 144. REST OF ASIA-PACIFIC AMYLASE MARKET, BY END-USE, 2024 - 2033 (KILOTON)
TABLE 145. LAMEA AMYLASE MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
TABLE 146. LAMEA AMYLASE MARKET, BY COUNTRY, 2024 - 2033 (KILOTON)
TABLE 147. LAMEA AMYLASE MARKET, BY SOURCE, 2024 - 2033 ($BILLION)
TABLE 148. LAMEA AMYLASE MARKET, BY SOURCE, 2024 - 2033 (KILOTON)
TABLE 149. LAMEA AMYLASE MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 150. LAMEA AMYLASE MARKET, BY TYPE, 2024 - 2033 (KILOTON)
TABLE 151. LAMEA AMYLASE MARKET, BY END-USE, 2024 - 2033 ($BILLION)
TABLE 152. LAMEA AMYLASE MARKET, BY END-USE, 2024 - 2033 (KILOTON)
TABLE 153. BRAZIL AMYLASE MARKET, BY SOURCE, 2024 - 2033 ($BILLION)
TABLE 154. BRAZIL AMYLASE MARKET, BY SOURCE, 2024 - 2033 (KILOTON)
TABLE 155. BRAZIL AMYLASE MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 156. BRAZIL AMYLASE MARKET, BY TYPE, 2024 - 2033 (KILOTON)
TABLE 157. BRAZIL AMYLASE MARKET, BY END-USE, 2024 - 2033 ($BILLION)
TABLE 158. BRAZIL AMYLASE MARKET, BY END-USE, 2024 - 2033 (KILOTON)
TABLE 159. SOUTH AFRICA AMYLASE MARKET, BY SOURCE, 2024 - 2033 ($BILLION)
TABLE 160. SOUTH AFRICA AMYLASE MARKET, BY SOURCE, 2024 - 2033 (KILOTON)
TABLE 161. SOUTH AFRICA AMYLASE MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 162. SOUTH AFRICA AMYLASE MARKET, BY TYPE, 2024 - 2033 (KILOTON)
TABLE 163. SOUTH AFRICA AMYLASE MARKET, BY END-USE, 2024 - 2033 ($BILLION)
TABLE 164. SOUTH AFRICA AMYLASE MARKET, BY END-USE, 2024 - 2033 (KILOTON)
TABLE 165. SAUDI ARABIA AMYLASE MARKET, BY SOURCE, 2024 - 2033 ($BILLION)
TABLE 166. SAUDI ARABIA AMYLASE MARKET, BY SOURCE, 2024 - 2033 (KILOTON)
TABLE 167. SAUDI ARABIA AMYLASE MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 168. SAUDI ARABIA AMYLASE MARKET, BY TYPE, 2024 - 2033 (KILOTON)
TABLE 169. SAUDI ARABIA AMYLASE MARKET, BY END-USE, 2024 - 2033 ($BILLION)
TABLE 170. SAUDI ARABIA AMYLASE MARKET, BY END-USE, 2024 - 2033 (KILOTON)
TABLE 171. REST OF LAMEA AMYLASE MARKET, BY SOURCE, 2024 - 2033 ($BILLION)
TABLE 172. REST OF LAMEA AMYLASE MARKET, BY SOURCE, 2024 - 2033 (KILOTON)
TABLE 173. REST OF LAMEA AMYLASE MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 174. REST OF LAMEA AMYLASE MARKET, BY TYPE, 2024 - 2033 (KILOTON)
TABLE 175. REST OF LAMEA AMYLASE MARKET, BY END-USE, 2024 - 2033 ($BILLION)
TABLE 176. REST OF LAMEA AMYLASE MARKET, BY END-USE, 2024 - 2033 (KILOTON)
TABLE 177. NOVOZYMES A/S: KEY EXECUTIVES
TABLE 178. NOVOZYMES A/S: COMPANY SNAPSHOT
TABLE 179. NOVOZYMES A/S: OPERATING SEGMENTS
TABLE 180. NOVOZYMES A/S: PRODUCT PORTFOLIO
TABLE 181. NOVOZYMES A/S: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 182. DSM: KEY EXECUTIVES
TABLE 183. DSM: COMPANY SNAPSHOT
TABLE 184. DSM: OPERATING SEGMENTS
TABLE 185. DSM: PRODUCT PORTFOLIO
TABLE 186. DSM: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 187. AB ENZYMES: KEY EXECUTIVES
TABLE 188. AB ENZYMES: COMPANY SNAPSHOT
TABLE 189. AB ENZYMES: OPERATING SEGMENTS
TABLE 190. AB ENZYMES: PRODUCT PORTFOLIO
TABLE 191. AB ENZYMES: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 192. CHEMZYME BIOTECHNOLOGY CO., LTD: KEY EXECUTIVES
TABLE 193. CHEMZYME BIOTECHNOLOGY CO., LTD: COMPANY SNAPSHOT
TABLE 194. CHEMZYME BIOTECHNOLOGY CO., LTD: OPERATING SEGMENTS
TABLE 195. CHEMZYME BIOTECHNOLOGY CO., LTD: PRODUCT PORTFOLIO
TABLE 196. CHEMZYME BIOTECHNOLOGY CO., LTD: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 197. SISCO RESEARCH LABORATORIES PVT LTD: KEY EXECUTIVES
TABLE 198. SISCO RESEARCH LABORATORIES PVT LTD: COMPANY SNAPSHOT
TABLE 199. SISCO RESEARCH LABORATORIES PVT LTD: OPERATING SEGMENTS
TABLE 200. SISCO RESEARCH LABORATORIES PVT LTD: PRODUCT PORTFOLIO
TABLE 201. SISCO RESEARCH LABORATORIES PVT LTD: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 202. KERRY GROUP: KEY EXECUTIVES
TABLE 203. KERRY GROUP: COMPANY SNAPSHOT
TABLE 204. KERRY GROUP: OPERATING SEGMENTS
TABLE 205. KERRY GROUP: PRODUCT PORTFOLIO
TABLE 206. KERRY GROUP: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 207. BIOLAXI CORPORATION: KEY EXECUTIVES
TABLE 208. BIOLAXI CORPORATION: COMPANY SNAPSHOT
TABLE 209. BIOLAXI CORPORATION: OPERATING SEGMENTS
TABLE 210. BIOLAXI CORPORATION: PRODUCT PORTFOLIO
TABLE 211. BIOLAXI CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 212. INTERNATIONAL FLAVORS AND FRAGRANCES INC.: KEY EXECUTIVES
TABLE 213. INTERNATIONAL FLAVORS AND FRAGRANCES INC.: COMPANY SNAPSHOT
TABLE 214. INTERNATIONAL FLAVORS AND FRAGRANCES INC.: OPERATING SEGMENTS
TABLE 215. INTERNATIONAL FLAVORS AND FRAGRANCES INC.: PRODUCT PORTFOLIO
TABLE 216. INTERNATIONAL FLAVORS AND FRAGRANCES INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 217. INFINITA BIOTECH PRIVATE LIMITED: KEY EXECUTIVES
TABLE 218. INFINITA BIOTECH PRIVATE LIMITED: COMPANY SNAPSHOT
TABLE 219. INFINITA BIOTECH PRIVATE LIMITED: OPERATING SEGMENTS
TABLE 220. INFINITA BIOTECH PRIVATE LIMITED: PRODUCT PORTFOLIO
TABLE 221. INFINITA BIOTECH PRIVATE LIMITED: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 222. ANTOZYME BIOTECH PRIVATE LIMITED: KEY EXECUTIVES
TABLE 223. ANTOZYME BIOTECH PRIVATE LIMITED: COMPANY SNAPSHOT
TABLE 224. ANTOZYME BIOTECH PRIVATE LIMITED: OPERATING SEGMENTS
TABLE 225. ANTOZYME BIOTECH PRIVATE LIMITED: PRODUCT PORTFOLIO
TABLE 226. ANTOZYME BIOTECH PRIVATE LIMITED: KEY STRATEGIC MOVES AND DEVELOPMENTS
LIST OF FIGURES
FIGURE 1. GLOBAL AMYLASE MARKET, 2024 - 2033
FIGURE 2. SEGMENTATION OF AMYLASE MARKET, 2024 - 2033
FIGURE 3. TOP INVESTMENT POCKET IN AMYLASE MARKET
FIGURE 4. MODERATE BARGAINING POWER OF BUYERS
FIGURE 5. MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 6. MODERATE THREAT OF NEW ENTRANTS
FIGURE 7. LOW THREAT OF SUBSTITUTION
FIGURE 8. HIGH COMPETITIVE RIVALRY
FIGURE 9. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALAMYLASE MARKET
FIGURE 10. GLOBAL AMYLASE MARKET SEGMENTATION, BY SOURCE
FIGURE 11. AMYLASE MARKET FOR MICROBES, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 12. AMYLASE MARKET FOR PLANTS, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 13. AMYLASE MARKET FOR ANIMALS, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 14. GLOBAL AMYLASE MARKET SEGMENTATION, BY TYPE
FIGURE 15. AMYLASE MARKET FOR ALPHA-AMYLASE, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 16. AMYLASE MARKET FOR BETA-AMYLASE, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 17. AMYLASE MARKET FOR GAMMA-AMYLASE, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 18. GLOBAL AMYLASE MARKET SEGMENTATION, BY END-USE
FIGURE 19. AMYLASE MARKET FOR FOOD AND BEVERAGE, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 20. AMYLASE MARKET FOR TEXTILE, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 21. AMYLASE MARKET FOR PAPER AND PULP, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 22. AMYLASE MARKET FOR PHARMACEUTICAL, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 23. AMYLASE MARKET FOR OTHERS, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 24. TOP WINNING STRATEGIES, BY YEAR, 2021-2023*
FIGURE 25. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2021-2023*
FIGURE 26. TOP WINNING STRATEGIES, BY COMPANY, 2021-2023*
FIGURE 27. PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 28. COMPETITIVE DASHBOARD
FIGURE 29. COMPETITIVE HEATMAP: AMYLASE MARKET
FIGURE 30. TOP PLAYER POSITIONING, 2023
FIGURE 31. NOVOZYMES A/S: NET SALES, 2021-2023 ($BILLION)
FIGURE 32. NOVOZYMES A/S: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 33. NOVOZYMES A/S: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 34. DSM: NET SALES, 2021-2023 ($BILLION)
FIGURE 35. DSM: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 36. DSM: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 37. AB ENZYMES: NET SALES, 2021-2023 ($BILLION)
FIGURE 38. AB ENZYMES: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 39. AB ENZYMES: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 40. CHEMZYME BIOTECHNOLOGY CO., LTD: NET SALES, 2021-2023 ($BILLION)
FIGURE 41. CHEMZYME BIOTECHNOLOGY CO., LTD: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 42. CHEMZYME BIOTECHNOLOGY CO., LTD: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 43. SISCO RESEARCH LABORATORIES PVT LTD: NET SALES, 2021-2023 ($BILLION)
FIGURE 44. SISCO RESEARCH LABORATORIES PVT LTD: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 45. SISCO RESEARCH LABORATORIES PVT LTD: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 46. KERRY GROUP: NET SALES, 2021-2023 ($BILLION)
FIGURE 47. KERRY GROUP: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 48. KERRY GROUP: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 49. BIOLAXI CORPORATION: NET SALES, 2021-2023 ($BILLION)
FIGURE 50. BIOLAXI CORPORATION: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 51. BIOLAXI CORPORATION: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 52. INTERNATIONAL FLAVORS AND FRAGRANCES INC.: NET SALES, 2021-2023 ($BILLION)
FIGURE 53. INTERNATIONAL FLAVORS AND FRAGRANCES INC.: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 54. INTERNATIONAL FLAVORS AND FRAGRANCES INC.: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 55. INFINITA BIOTECH PRIVATE LIMITED: NET SALES, 2021-2023 ($BILLION)
FIGURE 56. INFINITA BIOTECH PRIVATE LIMITED: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 57. INFINITA BIOTECH PRIVATE LIMITED: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 58. ANTOZYME BIOTECH PRIVATE LIMITED: NET SALES, 2021-2023 ($BILLION)
FIGURE 59. ANTOZYME BIOTECH PRIVATE LIMITED: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 60. ANTOZYME BIOTECH PRIVATE LIMITED: REVENUE SHARE, BY REGION, 2023 (%)

Companies Mentioned

  • Novozymes A/S
  • DSM
  • AB Enzymes
  • Chemzyme Biotechnology Co., Ltd
  • Sisco Research Laboratories Pvt Ltd
  • Kerry Group
  • Biolaxi Corporation
  • International Flavors & Fragrances Inc.
  • Infinita Biotech Private Limited
  • Antozyme Biotech Private Limited

Methodology

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages250
PublishedJune 2024
Forecast Period2023 - 2033
Estimated Market Value ( USD ) in 2023 $ 2.7 billion
Forecasted Market Value ( USD ) by 2033 $ 4.4 billion
Compound Annual Growth Rate5.1%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Global Alpha-Amylase Baking Enzyme Market by Source (Bacteria, Fungi, Plant-based), Application (Bread, Cookies & Biscuits, Desserts) - Forecast 2024-2030 - Product Image

Global Alpha-Amylase Baking Enzyme Market by Source (Bacteria, Fungi, Plant-based), Application (Bread, Cookies & Biscuits, Desserts) - Forecast 2024-2030

  • Report
  • 180 Pages
  • Global
From
Alpha Amylase Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region - Product Image

Alpha Amylase Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region

  • Report
  • 300 Pages
  • Global
Alpha-Amylase Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Image

Alpha-Amylase Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • 100 Pages
  • Global
From
Global Carbohydrase Market by Type (Amylases, Cellulases, Lactase), Application (Animal Feed, Food & Beverage, Pharmaceutical) - Forecast 2024-2030 - Product Image

Global Carbohydrase Market by Type (Amylases, Cellulases, Lactase), Application (Animal Feed, Food & Beverage, Pharmaceutical) - Forecast 2024-2030

  • Report
  • 185 Pages
  • Global
From
Amylase Determination Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type - Product Image

Amylase Determination Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • 96 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.